Back

Risperidone regulates the expression of schizophrenia-related genes in the murine forebrain

Ziemianska, M.; Zieba, M.; Radlicka-Borysewska, A.; Szumiec, L.; Golda, S.; Borczyk, M.; Piechota, M.; Korostynski, M.; Rodriguez Parkitna, J. M.

2025-08-22 pharmacology and toxicology
10.1101/2025.08.18.670814 bioRxiv
Show abstract

Risperidone acts on monoaminergic signaling to alleviate psychosis. At the cellular level, through both direct and indirect effects, the drug induces a specific pattern of gene expression, which differs between the basal ganglia and frontal cortex. These risperidone-regulated changes influence neuronal plasticity and are crucial for both its antipsychotic and extrapyramidal effects. Here, we employed sequencing-based spatial transcriptomics to comprehensively characterize gene expression changes in the male mouse (Mus musculus L.) forebrain after an acute dose of risperidone (0.5 mg/kg, i.p.). The transcriptional patterns were structure-specific, and unsupervised clustering of spatial profiles accurately identified cortical divisions, layers, and basal ganglia subregions. Differential gene expression was subsequently analyzed within each anatomically defined cluster using a customized statistical framework. Risperidone significantly altered the levels of 95 transcripts across 12 brain regions. The largest number of changes was observed in ventral brain areas, including the olfactory tubercle (25 differentially regulated transcripts), the diagonal band nucleus (22), the corpus callosum and commissures (13), and the lateral septal nucleus (9). Notably, 21 of the 95 differentially expressed genes were previously associated with schizophrenia, including Olig2, Smpd3, and Cacna1i. Overall, our results indicate that the strongest effects of risperidone are in medial and ventral brain regions rich in oligodendrocytes and glial cells. Furthermore, the enrichment analysis provides robust evidence of a molecular link between the drugs mechanism of action and genetic factors involved in schizophrenia. HighlightsO_LIUnsupervised clustering accurately identifies transcripts localization in the brain C_LIO_LIAcute risperidone treatment alters spatial transcriptional patterns of 95 genes C_LIO_LIRisperidone-regulated transcripts include 21 genes previously linked to schizophrenia C_LIO_LISpatial gene expression analysis offers novel insight into the drug action mechanism C_LI

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
British Journal of Pharmacology
40 papers in training set
Top 0.1%
21.7%
2
Biological Psychiatry
137 papers in training set
Top 0.2%
9.6%
3
Neuropsychopharmacology
153 papers in training set
Top 0.5%
6.7%
4
Translational Psychiatry
260 papers in training set
Top 1%
5.4%
5
Brain, Behavior, and Immunity
116 papers in training set
Top 0.3%
5.1%
6
Frontiers in Pharmacology
111 papers in training set
Top 0.5%
4.8%
50% of probability mass above
7
Biological Psychiatry Global Open Science
60 papers in training set
Top 0.2%
4.3%
8
Schizophrenia Research
35 papers in training set
Top 0.1%
4.0%
9
Molecular Psychiatry
282 papers in training set
Top 2%
3.5%
10
Neurobiology of Disease
148 papers in training set
Top 1%
3.2%
11
Scientific Reports
3612 papers in training set
Top 35%
3.2%
12
International Journal of Neuropsychopharmacology
14 papers in training set
Top 0.1%
1.9%
13
eLife
5828 papers in training set
Top 46%
1.9%
14
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 29%
1.7%
15
Schizophrenia
21 papers in training set
Top 0.2%
1.7%
16
Nature Communications
5641 papers in training set
Top 51%
1.1%
17
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.8%
1.1%
18
International Journal of Molecular Sciences
494 papers in training set
Top 14%
0.9%
19
Molecular Autism
33 papers in training set
Top 0.5%
0.6%
20
PLOS ONE
5266 papers in training set
Top 65%
0.6%
21
Frontiers in Neuroscience
256 papers in training set
Top 7%
0.6%
22
Schizophrenia Bulletin
32 papers in training set
Top 0.4%
0.6%
23
Neurochemistry International
10 papers in training set
Top 0.3%
0.6%
24
Communications Biology
993 papers in training set
Top 36%
0.6%